Phase Genomics lands $2.5M in fresh funding


The Seattle-based company says the funding will help target aberrations in cancer to help with treatment decisions.

Previous Point Ruston retail property in receivership goes under contract
Next Seattle-area home sales stay cool amid high interest rates, low inventory